60 likes | 84 Views
Everotas 10mg consist of an active ingredient known as Everolimus which is intrude with growth of cancer cell and process is slows down, this tablets is not a curable medication, which is helps to slow their spreading in to the body.
E N D
Apple Pharmaceuticals It is a fully licensed and regulated pharmacy, takes all precautions to strictly abide by the laws and regulations set forth in the dispensing of prescription medications.
Everolimus Everotas 10mg Tablets
Description • Indication • Primarily Everotas 10mg tablets indicated for the treatment • * kidney carcinoma • * Breast carcinoma • * Brain carcinoma • Everolimus is also indicated in various advanced stage cancer in stomach, intestines or pancreas. Everotas 10mg consist of an active ingredient known as Everolimus which is intrude with growth of cancer cell and process is slows down. Everotas 10mg tablets is not a curable medication, which is helps to slow their spreading in to the body.
Mechanism • Dosage and administration • Everotas 10mg tablets should be given with or without food. • Dosage regimen of Everotas 10mg: • In breast cancer, renal cell cancer, pancreatic cancer, Neuro endocrine cancer: • The prescribed dosage is 10mg should be taken as a single dose. • In Brain or intracranial cancer: • The prescribed dosage of Everotas as a single dose. is 4.5mg/m2 given orally • In pediatric: • The pediatric dosage of Everotas as a single dose in brain or intracranial tumor is 4.5mg/m2 should be given orally. Everolimus is an inhibitor of mTOR, joins at high compatibility to FK506 binding protein 12, via producing drug complex that inhibits the productive of mTOR. This inhibition reduces the activity of effectors downstream, which may lead to stoppage of cell progression from G1 into S phase, finally causes cell growth arrest and apoptosis
Pregnancy and lactation • Storage • Everotas 10mg tablet store at 25°C • Store the medicine away from moisture, heat and light Pregnancy category of Everolimus C In patients Everotas 10mg is used only after knowing the benefits to the mother exceed the risk to fetus. Breast feeding should not be suggested • Missed Dose • In case of missed dose, patients must consult with medical practitioner and follow the instructions given by them. Thereby missed dose should be avoid and follow the regular dosing schedule.
CONTACT US CALL ADDRESS • +91-9987711567 Apartment No.304 A Wing, Shiva Shakthi chs ltd, JP Road, Near Apna Bazar,Andheri(West),Mumbai - 400058.Maharashtra. MAIL • applepharamaceutical@gmail.com VISIT US http://anti-cancer-drugs.com/